Anti-TSPAN26 / CD37 Reference Antibody (otlertuzumab)
- Product Code: 140629
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in targeted cancer therapy, particularly for hematologic malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. Binds selectively to CD37, a protein highly expressed on B-cells, triggering cell death through apoptosis and immune-mediated mechanisms like antibody-dependent cellular cytotoxicity (ADCC). Investigated in clinical trials as a monotherapy and in combination with other agents to enhance anti-tumor response. Its humanized design reduces immunogenicity, supporting potential for repeated dosing in treatment regimens.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-TSPAN26 / CD37 Reference Antibody (otlertuzumab)
Used in targeted cancer therapy, particularly for hematologic malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. Binds selectively to CD37, a protein highly expressed on B-cells, triggering cell death through apoptosis and immune-mediated mechanisms like antibody-dependent cellular cytotoxicity (ADCC). Investigated in clinical trials as a monotherapy and in combination with other agents to enhance anti-tumor response. Its humanized design reduces immunogenicity, supporting potential for repeated dosing in treatment regimens.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :